{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:36:41Z","timestamp":1790631401281,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T00:00:00Z","timestamp":1645315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T00:00:00Z","timestamp":1645315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Free State of Bavaria","award":["BayVOC"],"award-info":[{"award-number":["BayVOC"]}]},{"name":"Free State of Bavaria","award":["FOR-COVID"],"award-info":[{"award-number":["FOR-COVID"]}]},{"name":"Universit\u00e4tsmedizin Greifswald"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Since autumn 2020, rapid antigen tests (RATs) have been implemented in several countries as an important pillar of the national testing strategy to rapidly screen for infections on site during the SARS-CoV-2 pandemic. The current surge in infection rates around the globe is driven by the variant of concern (VoC) omicron (B.1.1.529). Here, we evaluated the performance of nine SARS-CoV-2 RATs in a single-centre laboratory study. We examined a total of 115 SARS-CoV-2 PCR-negative and 166 SARS-CoV-2 PCR-positive respiratory swab samples (101 omicron, 65 delta (B.1.617.2)) collected from October 2021 until January 2022 as well as cell culture-expanded clinical isolates of both VoCs. In an assessment of the analytical sensitivity in clinical specimen, the 50% limit of detection (LoD50) ranged from 1.77\u2009\u00d7\u200910<jats:sup>6<\/jats:sup> to 7.03\u2009\u00d7\u200910<jats:sup>7<\/jats:sup> RNA copies subjected to the RAT for omicron compared to 1.32\u2009\u00d7\u200910<jats:sup>5<\/jats:sup> to 2.05\u2009\u00d7\u200910<jats:sup>6<\/jats:sup> for delta. To score positive in these point-of-care tests, up to 10-fold (LoD50) or 101-fold (LoD95) higher virus loads were required for omicron- compared to delta-containing samples. The rates of true positive test results for omicron samples in the highest virus load category (Ct values\u2009&lt;\u200925) ranged between 31.4 and 77.8%, while they dropped to 0\u20138.3% for samples with intermediate Ct values (25\u201330). Of note, testing of expanded virus stocks suggested a comparable RAT sensitivity of both VoCs, questioning the predictive value of this type of in vitro-studies for clinical performance. Given their importance for national test strategies in the current omicron wave, awareness must be increased for the reduced detection rate of omicron infections by RATs and a short list of suitable RATs that fulfill the minimal requirements of performance should be rapidly disclosed.<\/jats:p>","DOI":"10.1007\/s00430-022-00730-z","type":"journal-article","created":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T19:02:23Z","timestamp":1645383743000},"page":"105-117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["Impaired detection of omicron by SARS-CoV-2 rapid antigen tests"],"prefix":"10.1007","volume":"211","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5435-5972","authenticated-orcid":false,"given":"Andreas","family":"Osterman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Badell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Basara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7692-6905","authenticated-orcid":false,"given":"Marcel","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Kriesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Eletreby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze Naz","family":"\u00d6ztan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Autenrieth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricarda","family":"Knabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M.","family":"Sp\u00e4th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7016-0470","authenticated-orcid":false,"given":"Maximilian","family":"Muenchhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4435-6861","authenticated-orcid":false,"given":"Alexander","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5112-9507","authenticated-orcid":false,"given":"Stefan","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3994-2332","authenticated-orcid":false,"given":"Helmut","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Durner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7508-5841","authenticated-orcid":false,"given":"Ludwig","family":"Czibere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6441-3099","authenticated-orcid":false,"given":"Christopher","family":"D\u00e4chert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2359-2294","authenticated-orcid":false,"given":"Lars","family":"Kaderali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0589-697X","authenticated-orcid":false,"given":"Hanna-Mari","family":"Baldauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1384-8946","authenticated-orcid":false,"given":"Oliver T.","family":"Keppler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,20]]},"reference":[{"key":"730_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04387-1","author":"S Cele","year":"2021","unstructured":"Cele S, Jackson L, Khoury DS, Khan K, Moyo-Gwete T, Tegally H et al (2021) Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature. https:\/\/doi.org\/10.1038\/s41586-021-04387-1","journal-title":"Nature"},{"key":"730_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04389-z","author":"D Planas","year":"2021","unstructured":"Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J et al (2021) Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. https:\/\/doi.org\/10.1038\/s41586-021-04389-z","journal-title":"Nature"},{"issue":"7889","key":"730_CR3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-021-04005-0","volume":"600","author":"F Schmidt","year":"2021","unstructured":"Schmidt F, Weisblum Y, Rutkowska M, Poston D, DaSilva J, Zhang F et al (2021) High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape. Nature 600(7889):512\u2013516. https:\/\/doi.org\/10.1038\/s41586-021-04005-0","journal-title":"Nature"},{"key":"730_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01676-0","author":"H Gruell","year":"2022","unstructured":"Gruell H, Vanshylla K, Tober-Lau P, Hillus D, Schommers P, Lehmann C et al (2022) mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant. Nat Med. https:\/\/doi.org\/10.1038\/s41591-021-01676-0","journal-title":"Nat Med"},{"key":"730_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01715-4","author":"PR Wratil","year":"2022","unstructured":"Wratil PR, Stern M, Priller A, Willmann A, Almanzar G, Vogel E et al (2022) Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern. Nat Med. https:\/\/doi.org\/10.1038\/s41591-022-01715-4","journal-title":"Nat Med"},{"issue":"7858","key":"730_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41586-021-03470-x","volume":"593","author":"E Volz","year":"2021","unstructured":"Volz E, Mishra S, Chand M, Barrett JC, Johnson R, Geidelberg L et al (2021) Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature 593(7858):266\u2013269. https:\/\/doi.org\/10.1038\/s41586-021-03470-x","journal-title":"Nature"},{"key":"730_CR7","doi-asserted-by":"publisher","DOI":"10.1101\/2022.01.13.22269257","author":"JA Hay","year":"2022","unstructured":"Hay JA, Kissler SM, Fauver JR, Mack C, Tai CG, Samant RM et al (2022) Viral dynamics and duration of PCR positivity of the SARS-CoV-2 Omicron variant. medRxiv. https:\/\/doi.org\/10.1101\/2022.01.13.22269257","journal-title":"medRxiv"},{"key":"730_CR8","doi-asserted-by":"publisher","DOI":"10.1101\/2022.01.27.22269787","author":"BA Petros","year":"2022","unstructured":"Petros BA, Turcinovic J, Welch NL, White LF, Kolaczyk ED, Bauer MR et al (2022) Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations. medRxiv. https:\/\/doi.org\/10.1101\/2022.01.27.22269787","journal-title":"medRxiv"},{"key":"730_CR9","doi-asserted-by":"publisher","DOI":"10.1101\/2022.01.10.22269010","author":"O Puhach","year":"2022","unstructured":"Puhach O, Adea K, Hulo N, Sattonnet P, Genecand C, Iten A et al (2022) Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron. medRxiv. https:\/\/doi.org\/10.1101\/2022.01.10.22269010","journal-title":"medRxiv"},{"key":"730_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27588","author":"Y Araf","year":"2022","unstructured":"Araf Y, Akter F, Tang Y-D, Fatemi R, Parvez MSA, Zheng C et al (2022) Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.27588","journal-title":"J Med Virol"},{"issue":"10317","key":"730_CR11","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/s0140-6736(21)02758-6","volume":"398","author":"SSA Karim","year":"2021","unstructured":"Karim SSA, Karim QA (2021) Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet 398(10317):2126\u20132128. https:\/\/doi.org\/10.1016\/s0140-6736(21)02758-6 ((Epub 2021\/12\/07))","journal-title":"Lancet"},{"key":"730_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27561","author":"RK Mohapatra","year":"2022","unstructured":"Mohapatra RK, Sarangi AK, Kandi V, Azam M, Tiwari R, Dhama K (2022) Omicron (B1.1.529 variant of SARS-CoV-2); an emerging threat: current global scenario. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.27561","journal-title":"J Med Virol"},{"key":"730_CR13","unstructured":"Alaa Abdel Latif JLM, Manar A, Ginger T, Marco C, Emily H, Jerry Z, Mark Z, Emory H, Nate M, Chunlei W, Kristian GA, Andrew IS, Karthik G, Laura DH, and the Center for Viral Systems Biology. http:\/\/outbreak.info. Acccessed 22 Jul 2021"},{"key":"730_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.18.21268018","author":"M Bekliz","year":"2021","unstructured":"Bekliz M, Adea K, Alvarez C, Essaidi-Laziosi M, Escadafal C, Kaiser L et al (2021) Analytical sensitivity of seven SARS-CoV-2 antigen-detecting rapid tests for Omicron variant. medRxiv. https:\/\/doi.org\/10.1101\/2021.12.18.21268018","journal-title":"medRxiv"},{"issue":"8","key":"730_CR15","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1016\/S2666-5247(21)00147-6","volume":"2","author":"M Bekliz","year":"2021","unstructured":"Bekliz M, Adea K, Essaidi-Laziosi M, Sacks JA, Escadafal C, Kaiser L et al (2021) SARS-CoV-2 rapid diagnostic tests for emerging variants. Lancet Microbe 2(8):e351. https:\/\/doi.org\/10.1016\/S2666-5247(21)00147-6","journal-title":"Lancet Microbe"},{"issue":"7","key":"730_CR16","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1016\/S2666-5247(21)00056-2","volume":"2","author":"VM Corman","year":"2021","unstructured":"Corman VM, Haage VC, Bleicker T, Schmidt ML, M\u00fchlemann B, Zuchowski M et al (2021) Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study. Lancet Microbe 2(7):e311\u2013e319. https:\/\/doi.org\/10.1016\/S2666-5247(21)00056-2","journal-title":"Lancet Microbe"},{"issue":"9","key":"730_CR17","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3390\/microorganisms9091967","volume":"9","author":"S Jungnick","year":"2021","unstructured":"Jungnick S, Hobmaier B, Mautner L, Hoyos M, Haase M, Baiker A et al (2021) In vitro rapid antigen test performance with the SARS-CoV-2 variants of concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta). Microorganisms 9(9):1967. https:\/\/doi.org\/10.3390\/microorganisms9091967","journal-title":"Microorganisms"},{"issue":"1","key":"730_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00430-020-00698-8","volume":"210","author":"A Osterman","year":"2021","unstructured":"Osterman A, Baldauf HM, Eletreby M, Wettengel JM, Afridi SQ, Fuchs T et al (2021) Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting. Med Microbiol Immunol 210(1):65\u201372. https:\/\/doi.org\/10.1007\/s00430-020-00698-8 ((Epub 2021\/01\/17))","journal-title":"Med Microbiol Immunol"},{"issue":"5\u20136","key":"730_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00430-021-00719-0","volume":"210","author":"A Osterman","year":"2021","unstructured":"Osterman A, Iglhaut M, Lehner A, Sp\u00e4th P, Stern M, Autenrieth H et al (2021) Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern. Med Microbiol Immunol 210(5\u20136):263\u2013275. https:\/\/doi.org\/10.1007\/s00430-021-00719-0 ((Epub 2021\/08\/21))","journal-title":"Med Microbiol Immunol"},{"issue":"11","key":"730_CR20","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.3390\/v13112183","volume":"13","author":"Y Sakai-Tagawa","year":"2021","unstructured":"Sakai-Tagawa Y, Yamayoshi S, Halfmann PJ, Kawaoka Y (2021) Comparative sensitivity of rapid antigen tests for the delta variant (B.1.617.2) of SARS-CoV-2. Viruses 13(11):2183. https:\/\/doi.org\/10.3390\/v13112183","journal-title":"Viruses"},{"key":"730_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2807\/1560-7917.Es.2021.26.44.2100441","volume":"26","author":"H Scheiblauer","year":"2021","unstructured":"Scheiblauer H, Filomena A, Nitsche A, Puyskens A, Corman VM, Drosten C et al (2021) Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Euro Surveill 26:44. https:\/\/doi.org\/10.2807\/1560-7917.Es.2021.26.44.2100441 ((Epub 2021\/11\/06))","journal-title":"Euro Surveill"},{"key":"730_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/PATHOGENS10010038","volume":"10","author":"V Schildgen","year":"2021","unstructured":"Schildgen V, Demuth S, L\u00fcsebrink J, Schildgen O (2021) Limits and opportunities of SARS-CoV-2 antigen rapid tests: an experienced-based perspective. Pathogens 10:1. https:\/\/doi.org\/10.3390\/PATHOGENS10010038 ((Epub 2021\/01\/21))","journal-title":"Pathogens"},{"key":"730_CR23","doi-asserted-by":"publisher","first-page":"104713","DOI":"10.1016\/j.jcv.2020.104713","volume":"135","author":"T Toptan","year":"2021","unstructured":"Toptan T, Eckermann L, Pfeiffer AE, Hoehl S, Ciesek S, Drosten C et al (2021) Evaluation of a SARS-CoV-2 rapid antigen test: potential to help reduce community spread? J Clin Virol 135:104713. https:\/\/doi.org\/10.1016\/j.jcv.2020.104713 ((Epub 2020\/12\/23))","journal-title":"J Clin Virol"},{"issue":"2","key":"730_CR24","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1016\/S2666-5247(21)00302-5","volume":"3","author":"M Bekliz","year":"2022","unstructured":"Bekliz M, Adea K, Essaidi-Laziosi M, Sacks JA, Escadafal C, Kaiser L et al (2022) SARS-CoV-2 antigen-detecting rapid tests for the delta variant. Lancet Microbe 3(2):e90. https:\/\/doi.org\/10.1016\/S2666-5247(21)00302-5","journal-title":"Lancet Microbe"},{"key":"730_CR25","doi-asserted-by":"publisher","first-page":"103774","DOI":"10.1016\/j.ebiom.2021.103774","volume":"75","author":"LJ Kr\u00fcger","year":"2022","unstructured":"Kr\u00fcger LJ, Tanuri A, Lindner AK, Gaeddert M, K\u00f6ppel L, Tobian F et al (2022) Accuracy and ease-of-use of seven point-of-care SARS-CoV-2 antigen-detecting tests: a multi-centre clinical evaluation. EBioMedicine 75:103774. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103774 ((Epub 2021\/12\/28))","journal-title":"EBioMedicine"},{"key":"730_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013705.pub2","author":"J Dinnes","year":"2021","unstructured":"Dinnes J, Deeks JJ, Berhane S, Taylor M, Adriano A, Davenport C et al (2021) Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD013705.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"730_CR27","doi-asserted-by":"publisher","DOI":"10.1101\/2022.01.04.22268770","author":"B Adamson","year":"2022","unstructured":"Adamson B, Sikka R, Wyllie AL, Premsrirut P (2022) Discordant SARS-CoV-2 PCR and rapid antigen test results when infectious: a December 2021 occupational case series. medRxiv. https:\/\/doi.org\/10.1101\/2022.01.04.22268770","journal-title":"medRxiv"},{"key":"730_CR28","doi-asserted-by":"publisher","DOI":"10.1101\/2022.01.08.22268954","author":"J Schrom","year":"2022","unstructured":"Schrom J, Marquez C, Pilarowski G, Wang G, Mitchell A, Puccinelli R et al (2022) Direct comparison of SARS Co-V-2 nasal RT-PCR and rapid antigen test (BinaxNOW\u2122) at a community testing site during an Omicron surge. medRxiv. https:\/\/doi.org\/10.1101\/2022.01.08.22268954","journal-title":"medRxiv"},{"key":"730_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.02479-21","author":"J Deerain","year":"2021","unstructured":"Deerain J, Druce J, Tran T, Batty M, Yoga Y, Fennell M et al (2021) Assessment of the analytical sensitivity of ten lateral flow devices against the SARS-CoV-2 omicron variant. J Clin Microbiol. https:\/\/doi.org\/10.1128\/jcm.02479-21 ((Epub 2021\/12\/23))","journal-title":"J Clin Microbiol"},{"key":"730_CR30","unstructured":"European Commission. EU health preparedness: A common list of COVID-19 rapid antigen tests; A common standardised set of data to be included in COVID-9 test result certificates; and A common list of COVID-19 laboratory based antigenic assays. https:\/\/ec.europa.eu\/health\/system\/files\/2022-01\/covid-19_rat_common-list_en.pdf. Accessed 07 Jul 2022"},{"key":"730_CR31","unstructured":"Centers for Disease Control and Prevention (CDC) Information for laboratories about coronavirus (COVID-19). https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/index.html. Accessed 2 Jul 2022"},{"key":"730_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-022-00728-7","author":"C D\u00e4chert","year":"2022","unstructured":"D\u00e4chert C, Muenchhoff M, Graf A, Autenrieth H, Bender S, Mairhofer H et al (2022) Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants. Med Microbiol Immunol. https:\/\/doi.org\/10.1007\/s00430-022-00728-7 ((Epub 2022\/01\/22))","journal-title":"Med Microbiol Immunol"},{"issue":"9","key":"730_CR33","doi-asserted-by":"publisher","first-page":"e3055","DOI":"10.1093\/cid\/ciaa1935","volume":"73","author":"T Weinberger","year":"2021","unstructured":"Weinberger T, Steffen J, Osterman A, Mueller TT, Muenchhoff M, Wratil PR et al (2021) Prospective longitudinal serosurvey of healthcare workers in the first wave of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in a quaternary care hospital in Munich, Germany. Clin Infect Dis 73(9):e3055\u2013e3065. https:\/\/doi.org\/10.1093\/cid\/ciaa1935 ((Epub 2021\/01\/04))","journal-title":"Clin Infect Dis"},{"key":"730_CR34","doi-asserted-by":"publisher","first-page":"102715","DOI":"10.1016\/j.jaut.2021.102715","volume":"124","author":"SR Kannan","year":"2021","unstructured":"Kannan SR, Spratt AN, Cohen AR, Naqvi SH, Chand HS, Quinn TP et al (2021) Evolutionary analysis of the delta and delta plus variants of the SARS-CoV-2 viruses. J Autoimmun 124:102715. https:\/\/doi.org\/10.1016\/j.jaut.2021.102715 ((Epub 2021\/08\/11))","journal-title":"J Autoimmun"},{"key":"730_CR35","doi-asserted-by":"publisher","DOI":"10.1101\/2022.01.28.22269968","author":"S Stanley","year":"2022","unstructured":"Stanley S, Hamel DJ, Wolf ID, Riedel S, Dutta S, Cheng A et al (2022) Limit of detection for rapid antigen testing of the SARS-CoV-2 Omicron variant. medRxiv. https:\/\/doi.org\/10.1101\/2022.01.28.22269968","journal-title":"medRxiv"},{"key":"730_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2807\/1560-7917.Es.2021.26.44.2100442","volume":"26","author":"A Puyskens","year":"2021","unstructured":"Puyskens A, Krause E, Michel J, N\u00fcbling CM, Scheiblauer H, Bourquain D et al (2021) Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Euro Surveill 26:44. https:\/\/doi.org\/10.2807\/1560-7917.Es.2021.26.44.2100442 ((Epub 2021\/11\/06))","journal-title":"Euro Surveill"},{"issue":"1","key":"730_CR37","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1038\/s41467-020-19619-7","volume":"11","author":"S Klein","year":"2020","unstructured":"Klein S, Cortese M, Winter SL, Wachsmuth-Melm M, Neufeldt CJ, Cerikan B et al (2020) SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography. Nat Commun 11(1):5885. https:\/\/doi.org\/10.1038\/s41467-020-19619-7","journal-title":"Nat Commun"},{"key":"730_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.603509","author":"T Liu","year":"2020","unstructured":"Liu T, Jia P, Fang B, Zhao Z (2020) Differential expression of viral transcripts from single-cell RNA sequencing of moderate and severe COVID-19 patients and its implications for case severity. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2020.603509","journal-title":"Front Microbiol"},{"key":"730_CR39","unstructured":"Paul-Ehrlich-Institute. SARS-CoV-2-Antigentests f\u00fcr Nachweis der Omikron-Infektion geeignet (in German). https:\/\/www.pei.de\/DE\/newsroom\/hp-meldungen\/2021\/211230-antigentests-omikron-variante.html. Accessed 2 Jul 2022"},{"key":"730_CR40","unstructured":"Gesundheitministerium f\u00fcr Gesundheit. Fragen und Antworten zu Quarant\u00e4ne- und Isolierungsregeln (in German). https:\/\/www.bundesgesundheitsministerium.de\/coronavirus\/faq-quarantaene-isolierungsregeln.html#c23632. Accessed 2 Jul 2022"},{"key":"730_CR41","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfarM). Antigen-Tests auf SARS-CoV-2 zur Eigenanwendung, die Gegenstand des Anspruchs nach \u00a71 Satz 1 Coronavirus-Testverordnung (TestV) sind (\u201eSelbsttests\u201c) (in German). https:\/\/antigentest.bfarm.de\/ords\/f?p=ANTIGENTESTS-AUF-SARS-COV-2:TESTS-ZUR-EIGENANWENDUNG-DURCH-LAIEN:11537849404532:::::&tz=1:00. Accessed 2 Jun 2022"},{"issue":"7","key":"730_CR42","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jiph.2020.05.023","volume":"13","author":"J Lin","year":"2020","unstructured":"Lin J, Yan K, Zhang J, Cai T, Zheng J (2020) A super-spreader of COVID-19 in Ningbo city in China. J Infect Public Health 13(7):935\u2013937. https:\/\/doi.org\/10.1016\/j.jiph.2020.05.023","journal-title":"J Infect Public Health"},{"key":"730_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.822633","author":"L-T Liu","year":"2022","unstructured":"Liu L-T, Tsai J-J, Chen C-H, Lin P-C, Tsai C-Y, Tsai Y-Y et al (2022) Isolation and identification of a rare spike gene double-deletion SARS-CoV-2 variant from the patient with high cycle threshold value. Front Med. https:\/\/doi.org\/10.3389\/fmed.2021.822633","journal-title":"Front Med"},{"key":"730_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2807\/1560-7917.Es.2020.25.32.2001483","volume":"25","author":"A Singanayagam","year":"2020","unstructured":"Singanayagam A, Patel M, Charlett A, Lopez Bernal J, Saliba V, Ellis J et al (2020) Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill 25:32. https:\/\/doi.org\/10.2807\/1560-7917.Es.2020.25.32.2001483 ((Epub 2020\/08\/15))","journal-title":"Euro Surveill"},{"issue":"28","key":"730_CR45","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1073\/pnas.2009799117","volume":"117","author":"M Imai","year":"2020","unstructured":"Imai M, Iwatsuki-Horimoto K, Hatta M, Loeber S, Halfmann PJ, Nakajima N et al (2020) Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci 117(28):16587\u201316595. https:\/\/doi.org\/10.1073\/pnas.2009799117","journal-title":"Proc Natl Acad Sci"},{"issue":"573","key":"730_CR46","doi-asserted-by":"publisher","first-page":"eabe2555","DOI":"10.1126\/scitranslmed.abe2555","volume":"12","author":"A Popa","year":"2020","unstructured":"Popa A, Genger J-W, Nicholson MD, Penz T, Schmid D, Aberle SW et al (2020) Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Sci Transl Med 12(573):eabe2555. https:\/\/doi.org\/10.1126\/scitranslmed.abe2555","journal-title":"Sci Transl Med"},{"key":"730_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27560","author":"K Ito","year":"2021","unstructured":"Ito K, Piantham C, Nishiura H (2021) Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.27560 ((Epub 2021\/12\/31))","journal-title":"J Med Virol"},{"key":"730_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm11010030","volume":"11","author":"H Nishiura","year":"2021","unstructured":"Nishiura H, Ito K, Anzai A, Kobayashi T, Piantham C, Rodr\u00edguez-Morales AJ (2021) Relative reproduction number of SARS-CoV-2 Omicron (B.1.1.529) compared with delta variant in South Africa. J Clin Med 11:1. https:\/\/doi.org\/10.3390\/jcm11010030 ((Epub 2022\/01\/12))","journal-title":"J Clin Med"},{"key":"730_CR49","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2147\/clep.S311977","volume":"13","author":"I Petersen","year":"2021","unstructured":"Petersen I, Crozier A, Buchan I, Mina MJ, Bartlett JW (2021) Recalibrating SARS-CoV-2 antigen rapid lateral flow test relative sensitivity from validation studies to absolute sensitivity for indicating individuals shedding transmissible virus. Clin Epidemiol 13:935\u2013940. https:\/\/doi.org\/10.2147\/clep.S311977 ((Epub 2021\/10\/28))","journal-title":"Clin Epidemiol"},{"key":"730_CR50","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1121993\/v1","author":"K Ben","year":"2022","unstructured":"Ben K, Alex M, Mariya K, Alison B, Niluka G, Jie Z et al (2022). Nat Portfolio. https:\/\/doi.org\/10.21203\/rs.3.rs-1121993\/v1","journal-title":"Nat Portfolio"},{"key":"730_CR51","unstructured":"Paul-Ehrlich-Institute. Mindestkriterien f\u00fcr SARS-CoV-2 Antigentests im Sinne von \u00a7 1 Abs. 1 Satz 1 TestVO: antigenschnelltests (in German). https:\/\/www.pei.de\/SharedDocs\/Downloads\/DE\/newsroom\/dossiers\/mindestkriterien-sars-cov-2-antigentests-01-12-2020.pdf?__blob=publicationFile. Accessed 2 Jul 2022."},{"key":"730_CR52","unstructured":"World Health Organization (WHO) (2020) Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays. https:\/\/www.who.int\/publications\/i\/item\/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays. Accessed 2 Jul 2022"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-022-00730-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-022-00730-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-022-00730-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T08:04:22Z","timestamp":1652774662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-022-00730-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,20]]},"references-count":52,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["730"],"URL":"https:\/\/doi.org\/10.1007\/s00430-022-00730-z","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,20]]},"assertion":[{"value":"9 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was not required because all samples used were residual samples. Samples were identified in the laboratory and assigned a number without reference to patient or clinical details. Results from testing using the study assays did not impact on clinical care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data and materials availability"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}